Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026

Go back to Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026
(NASDAQ: CRVS) Delayed: 14.39 -0.26 (1.77%)
Previous Close $14.65    52 Week High $17.77 
Open $14.34    52 Week Low $9.63 
Day High $14.74    P/E N/A 
Day Low $14.34    EPS $0.00 
Volume 626,950